Sector: MedicalEnzon Pharmaceuticals, Inc. (NASDAQ: ENZN)
Headlines
- Enzon Presents Data at 2009 EORTC Meeting
Nov 19, 2009 09:19 AM | ENZN
- Enzon to Present Data at EORTC-NCI-AACR
Nov 16, 2009 03:24 PM | ENZN
- Enzon Announces Agreement to Sell Specialty Pharmaceutical Business
Nov 09, 2009 08:30 AM | ENZN
- Epistem Presents GenetRx(TM) Clinical Data on the Use of Scalp Hair to Assess Androgen Receptor Directed Therapies and to Identify Novel Pharmacodynamic Markers for an Antisense Molecule
Nov 09, 2009 02:01 AM | ENZN
- Enzon Reports Third Quarter 2009 Results
Nov 03, 2009 08:17 AM | ENZN
- Enzon to Release Third Quarter 2009 Earnings on Tuesday, November 3, 2009; Conference Call and Webcast to Follow
Oct 28, 2009 03:00 PM | ENZN
- 15 Breakout Stocks On Huge Volume
Oct 08, 2009 09:51 AM | BRCD, CGR, ENZN, GIII, ICTG, MBRX
- UCB's Cimzia(R), the Only PEGylated Anti-TNF, Approved in Europe
Oct 06, 2009 10:35 AM | ENZN
- PEGINTRON(R) Receives a Recommendation for Approval from FDA Advisory Committee for a New Application in Melanoma
Oct 05, 2009 02:44 PM | ENZN, SGP
- Enzon to Present at Newsmakers in the Biotech Industry Conference
Sep 10, 2009 03:21 PM | ENZN
- Enzon Reports 2nd Quarter 2009 Results
Aug 04, 2009 08:25 AM | ENZN
- CORRECTING and REPLACING Enzon to Present at BMO Focus on Healthcare Conference
Jul 28, 2009 09:34 AM | ENZN
- Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Jul 27, 2009 01:01 PM | ENZN
- Enzon to Present at BMO Focus on Healthcare Conference
Jul 27, 2009 10:26 AM | ENZN
- DellaCamera Comments on Recent Replacement of Jeffrey H. Buchalter as Chairman of Enzon and Addition of New Independent Director to Enzon’s Board
Jul 23, 2009 04:46 PM | ENZN
- Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
Jul 23, 2009 04:34 PM | ENZN
- DellaCamera Advised That Enzon Has Set July 24, 2009 as Record Date for Consent Solicitation
Jul 21, 2009 04:09 PM | ENZN
- DellaCamera Makes Formal Request for Enzon to Set Record Date for Consent Solicitation
Jul 07, 2009 12:07 PM | ENZN
- Enzon Commences Phase II Trial of PEG-SN38
Jun 22, 2009 04:01 PM | ENZN
- DellaCamera Reports on Town Hall Meeting for Enzon Shareholders and Provides Update on Consent Solicitation Process
Jun 17, 2009 10:05 AM | ENZN
- Form 4 HORAK IVAN D For: Sep 02 (10K)
Sep 04, 2009 09:00 PM
- Form 3 ENZON PHARMACEUTICALS For: Jul 23 Filed by: IRIDIAN ASSET MANAGEMENT LLC/CT (10K)
Jul 31, 2009 06:00 PM
- Form 3 Levy Harold J For: Jul 23 (10K)
Jul 31, 2009 06:00 PM
- Form 4 Denner Alexander J For: May 21 (10K)
May 26, 2009 06:52 PM
- Form 3 Denner Alexander J For: May 21 (10K)
May 26, 2009 06:49 PM
- Form 4 Mulligan Richard For: May 21 (10K)
May 26, 2009 05:34 PM
- Form 4 TOOMAN CRAIG A For: Apr 03 (10K)
Apr 07, 2009 05:16 PM
- Form 4 del Campo Ralph For: Apr 03 (10K)
Apr 07, 2009 05:15 PM
- Form 4 Davit Paul Stephen For: Apr 03 (10K)
Apr 07, 2009 05:13 PM
- Form 4 HORAK IVAN D For: Apr 03 (10K)
Apr 07, 2009 05:09 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ENZN
|
Compare to S&P
|
| YTD |
69.47 %
|
39.99 %
|
| 4 Weeks |
7.63 %
|
7.05 %
|
| 12 Weeks |
33.15 %
|
24.95 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 100.00 %
|
|
EPS Growth in Last Year: 100.00 %
|
|
Sales Growth in Last Quarter: -5.49 %
|
|
Sales Growth in Last Quarter: -8.59 %
|
|
